Bovine vs porcine gelatin for capsules: what should buyers know?

Beyond Biopharma · Pharmaceutical Gelatin FAQ

Both bovine and porcine gelatin can produce excellent, interchangeable capsule shells, so for many capsule applications the functional difference is small. What buyers must weigh instead is source and process character: bovine gelatin usually comes from hides or bones and is typically made by an alkaline (lime) pretreatment into Type B gelatin, while porcine gelatin comes from pig skin and is generally made by an acid process into Type A gelatin. Religious and cultural rules differ between the two sources, bovine gelatin is the one with BSE/TSE and traceability documentation considerations, and each carries its own allergen, labelling and regional supply implications. Selection therefore tends to be driven by target market religion, supply security, and the documentation the finished-capsule buyer needs, with the final per-batch status confirmed against supplier certificates of analysis and any applicable regulations.

Two animal sources, two families of product

Gelatin for capsule shells is overwhelmingly either porcine (from pig skin) or bovine (from cattle). The distinction matters far more in the sourcing and compliance world than in the shell itself, because once both are purified to pharmaceutical grade their gelling, film-forming and dissolution behaviour overlaps closely enough that a formulator can usually switch between them without redesigning the product.

Porcine gelatin

Porcine gelatin is traditionally the most common type used in hard and soft capsule shells worldwide, largely because pig skin is abundant. It is a Type A gelatin, produced with an acid pretreatment and an isoelectric point around pH 7–9.

Bovine gelatin

Bovine gelatin comes from cattle hides or bones and is characteristically a Type B gelatin made by an alkaline (lime or caustic) process, with an isoelectric point around pH 4.5–5.5. Like porcine gelatin, it can also be made by acid treatment (Type A), so the type label does not strictly guarantee the animal; the certificate and supplier declaration are the definitive source record.

A practical buyer’s comparison table

DimensionPorcineBovine
Raw materialPig skinCattle hide or bone
Typical processAcid (Type A)Alkaline/lime (usually Type B)
Religious acceptanceNot generally halal/kosherHalal/kosher possible with certified slaughter and process
BSE/TSE documentationTypically lighterRequired depending on market; confirm with the supplier
Availability / regional preferenceVery high volume; a common defaultWidely used, especially where halal/kosher or porcine avoidance is required

Why buyers must look past “gelatin” on the spec

Because the capsule application is essentially the same, buyers should confirm the animal source explicitly in a supplier questionnaire or certificate, and not assume it from a Type A/B label. Different finished-product markets impose different expectations — a religious market, a vegan/vegetarian or porcine-avoiding population, or one sensitive to bovine materials may each drive a different sourcing decision — and allergen, labelling and local regulatory rules can change, so each region’s current requirements should be verified at the time of supply.

How sourcing strategy usually plays out

  1. Start from the market — determine whether the target market mandates halal, kosher, porcine-free or bovine-free positioning, because that decides the animal source before any technical comparison.
  2. Confirm compatibility — for most standard capsules the two sources interconvert with no change to the dosage form, so the technical risk is low.
  3. Secure documentation — obtain the source declaration, certificates and any religious or TSE documentation that the finished product requires, and keep it current.
  4. Balance supply security — compare regional availability and cost, then consult your regulatory affairs and quality teams and your suppliers to lock the compliant choice.

Where a pharma buyer specifically needs BSE/TSE paperwork for bovine material, see our dedicated BSE/TSE documentation question.

CONTACT

Your Name:*

Country:*

Company:*

Email:*

Phone (with Country Code)*

Message:*